Talking ATTD, 780G, Rumors And Missteps With Medtronic’s Diabetes Leaders
Executive Summary
Medtech Insight spoke to the president of Medtronic’s diabetes business, Que Dallara, as well as two of the company’s medical affairs directors, about the company’s recently published data, and the timeline for the US launch of its 780G system.
You may also be interested in...
‘Closest To What The Pancreas Would Actually Do’: Medtronic Diabetes Execs On Marketing Plans For MiniMed 780G
In this third Exec Chat with leaders at major diabetes companies that presented at ADA’s Scientific Sessions 2023, Medtech Insight interviewed Medtronic diabetes business leaders Ali Dianaty and Jennifer McVean about the company’s marketing strategy for the recently launched MiniMed 780G with meal detection technology, plans for the Simplera disposable CGM, outlook on the consumer market, and more.
Medtronic MiniMed 780G Data Shows Simplified Meal Management Helps Users With Glycemic Target
Medtronic announced data at the ADA conference today showing the MiniMed 780G advanced hybrid close loop system’s meal detection technology helps reduce time spent in hyperglycemia.
News We're Watching: Renal Denervation Trial Highlights, TAP Pilot Update, Cardiohelp Safety Alert
Two new studies support ReCor’s Radiance Ultrasound Renal Denervation System, and renal denervation also won the backing of European medical societies. Additionally, the FDA issued an update on the Total Product Life Cycle Advisory Program (TAP) “soft” pilot, and a disposable component of the Getinge/Maquet Cardiohelp system was flagged for possible sterility issues.